The unmet need for COVID-19 treatment in immunocompromised patients

The unmet need for COVID-19 treatment in immunocompromised patients

Abstract Background Immunocompromised (IC) patients are at increased risk of severe and/or prolonged COVID-19. Main text The recent study by Scaglione et al., addresses the issue of IC outpatients with SARS-CoV-2 infection. Authors describe the real-life use of SARS-CoV-2 antivirals and/or monoclona...

Full description

Bibliographic Details
Main Authors: D’Abramo Alessandra, Vita Serena, Nicastri Emanuele
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Infectious Diseases
Subjects:
Immunocompromised patients
Severe and/or prolonged COVID-19
Passive immunotherapy
Antiviral therapy
Combined therapy
Online Access:https://doi.org/10.1186/s12879-022-07918-x

Internet

https://doi.org/10.1186/s12879-022-07918-x

Similar Items